BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37688398)

  • 1. Non-invasive diagnosis of early cutaneous squamous cell carcinoma.
    Azimi A; Jabbour S; Patrick E; Fernandez-Penas P
    Exp Dermatol; 2023 Nov; 32(11):1946-1959. PubMed ID: 37688398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
    Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
    Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors.
    Azimi A; Kaufman KL; Kim J; Ali M; Mann GJ; Fernandez-Penas P
    J Dermatol Sci; 2020 Jul; 99(1):9-16. PubMed ID: 32312638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency ultrasound in the diagnosis of the spectrum of cutaneous squamous cell carcinoma: Noninvasively distinguishing actinic keratosis, Bowen's Disease, and invasive squamous cell carcinoma.
    Zhu AQ; Wang LF; Li XL; Wang Q; Li MX; Ma YY; Xiang LH; Guo LH; Xu HX
    Skin Res Technol; 2021 Sep; 27(5):831-840. PubMed ID: 33751714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
    Yoshifuku A; Fujii K; Kanekura T
    J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
    Leiter U; Heppt MV; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; ElGammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1422-1433. PubMed ID: 37840404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
    Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C
    Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L; Cuevas J; Juarranz A
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
    Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
    J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
    Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
    Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma.
    Luo T; Lu Y; Liu S; Lin D; Qu J
    Anal Chem; 2017 Aug; 89(15):8104-8111. PubMed ID: 28661125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.